News About the Dean

Artificial intelligence is creating new opportunities to advance discovery, education, patient care, and the way we work. In this conversation, Dr. Mary E. Klotman, sits down with Dr. Christopher Lindsell, vice dean for data science and AI for the Duke University School of Medicine, to discuss Duke's vision for AI and data science.

David Tuveson, MD, PhD, will join Duke Health as executive director of the Duke Cancer Institute (DCI), effective October 31, 2026.  Tuveson, a preeminent cancer biologist, is currently the Roy J. Zuckerberg Professor of Cancer Research and director of the National Cancer Institute-Designated Cancer Center at Cold Spring Harbor Laboratory. He is also the chief scientist for the Lustgarten Foundation for Pancreatic Cancer Research.

What inspires the next generation of physicians and physician-scientists? In this conversation, Dean Mary Klotman sits down with Ashley Truong, an MD-PhD student, and Divyam Goel, an MD student, to discuss their journeys to Duke, the experiences shaping their education, and their vision for the future of health care.

At the 57th annual Duke University Medical School Student Research Symposium, students shared discoveries born from an immersive third-year research experience.

In this candid conversation, Dr. Mary E. Klotman, executive vice president for health affairs of Duke University, dean of the Duke University School of Medicine, and chief academic officer of Duke Health, sits down with Dr. David W. Zaas, chief executive officer of Duke University Health System, to talk about what's ahead.

Dr. Antiel is a nationally recognized scholar whose work spans pediatric medical ethics and medical humanities.

SriniVas Sadda, MD, FARVO, will join Duke Health as chair of the Department of Ophthalmology effective November 10, 2026.  An internationally recognized leader in ophthalmology, Sadda’s work has advanced the field through innovations in retinal imaging, data science, and clinical care. He brings a vision for integrating research and patient care, and he is well positioned to lead Duke Ophthalmology into its next phase of growth and impact. 

In this conversation, Dr. Gupta discusses the growing shift in aging science from extending lifespan to improving healthspan – how well we live as we age. He shares insights from his research on metabolic resilience, healthy aging, and the biological systems that help the body adapt over time. Dr. Gupta also highlights interdisciplinary collaborations at Duke, including work related to GLP‑1–based therapies and their potential impact beyond weight loss.

Dr. Naggie highlights why strong community relationships are essential to clinical trials and translational science. She shares the value of building trust and increasing access to ensure research reflects the needs of the people it aims to serve.

In this conversation, Dr. Swamy reflects on the significant progress made over the past year as Duke adapted to national shifts in research funding, strengthened operational systems, and enhanced support for investigators. She highlights the strategic changes shaping how research is conducted at Duke, the importance of sharing the story of research through the Duke Research Saves Lives campaign, and the role of technology in transforming operations.